StockUnited StatesNasdaqGS

ARWR

Arrowhead Pharmaceuticals, Inc.

Healthcare · Biotechnology

82.63USD

-2.4800 (-2.91%)

Description Historical Financials Relative Value Research News Discussion OptionsPrice Chart ↗Fundamental Chart ↗

Fiscal Year End09/2025

Last Quarter End06/2026 Q3

Current/T12M(USD)

Issue Data

Last PxUSD / 82.63

P/E—

Dvd Ind Yld—

P/B25.07

P/S17.4

Curr EV/T12M EBITDA-57.1

Mkt Cap (USD)11.7B

Curr EV (USD)11.5B

Per Share Data

EPS T12M-2.25

DPS—

Bk Val Per Sh3.30

Rev/Sh4.67

Cash/Sh11.31

Curr Shares Out141.3M

FCF/Sh-0.52

Cash Flow Analysis

P/CF-197.6

Curr P/FCF-155.4

CF/NI0.2

Dvd P/O0.0%

Cash Gen/Cash Reqd—

Csh Dvd Cov—

CFO/Sales-8.8%

Eff Interest Rate6.7%

Growth Potential

Dil EPS 1Y Gr99.8%

Cap 1Y Gr151.3%

BPS 1Y Gr125.1%

R&D To Sales108.0%

Retention Rate100.0%

Rev 1Y Gr23258.2%

FCF 1Y Gr126.0%

Assets 1Y Gr21.5%

Profitability

EBITDA-0.2B

EBIT-0.2B

Operating Margin-33.8%

Pretax Margin-37.7%

Net Margin-47.8%

ROA-18.3%

ROE-64.8%

ROC—

Asset Turnover0.38

Structure

Current Ratio5.90

Quick Ratio5.71

Debt/Assets65.3%

Debt/Com Eq296.3%

Net Debt/EBITDA-6.47

Tot Debt/Capital74.8%

Gross Margin100.0%

EBIT/Int Exp-2.4

Returns and turnover use the AVERAGE balance over the year, not the closing snapshot. Growth rates compare the two most recent fiscal years.

Reading financial statements from SEC filings…

A first visit to a security takes a few seconds.